Mesomelic dysplasia, Kantaputra type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1836OMIM:156232Q78.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mesomelic dysplasia, Kantaputra type is an extremely rare skeletal disorder characterized by disproportionate shortening of the middle segments (mesomelic segments) of the limbs, specifically the forearms and lower legs. This condition belongs to the broader group of mesomelic dysplasias, which are a heterogeneous set of skeletal disorders affecting the long bones of the limbs. The Kantaputra type was first described in a Thai family and is distinguished by its specific pattern of skeletal involvement. Key clinical features include shortening and bowing of the radius and ulna in the forearms, as well as shortening of the tibia and fibula in the lower legs. Affected individuals may also exhibit abnormalities of the hands and feet, including brachydactyly (short fingers and toes) and carpal/tarsal bone anomalies. The axial skeleton (spine) is generally not significantly affected. Stature is reduced due to the limb shortening, but intelligence and other organ systems are typically normal. There is currently no specific cure or targeted therapy for mesomelic dysplasia, Kantaputra type. Management is supportive and symptomatic, potentially involving orthopedic interventions to address limb deformities or functional limitations. Regular monitoring by a multidisciplinary team including clinical geneticists and orthopedic specialists is recommended. Genetic counseling is important for affected families given the hereditary nature of the condition.

Also known as:

Clinical phenotype terms— hover any for plain English:

MesomeliaHP:0003027Abnormality of the ankleHP:0003028Dumbbell-shaped humerusHP:0005009Ulnar deviation of fingerHP:0009465Abnormal humerus morphologyHP:0031095
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mesomelic dysplasia, Kantaputra type.

View clinical trials →

No actively recruiting trials found for Mesomelic dysplasia, Kantaputra type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mesomelic dysplasia, Kantaputra type community →

No specialists are currently listed for Mesomelic dysplasia, Kantaputra type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mesomelic dysplasia, Kantaputra type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mesomelic dysplasia, Kantaputra typeForum →

No community posts yet. Be the first to share your experience with Mesomelic dysplasia, Kantaputra type.

Start the conversation →

Latest news about Mesomelic dysplasia, Kantaputra type

No recent news articles for Mesomelic dysplasia, Kantaputra type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mesomelic dysplasia, Kantaputra type

What is Mesomelic dysplasia, Kantaputra type?

Mesomelic dysplasia, Kantaputra type is an extremely rare skeletal disorder characterized by disproportionate shortening of the middle segments (mesomelic segments) of the limbs, specifically the forearms and lower legs. This condition belongs to the broader group of mesomelic dysplasias, which are a heterogeneous set of skeletal disorders affecting the long bones of the limbs. The Kantaputra type was first described in a Thai family and is distinguished by its specific pattern of skeletal involvement. Key clinical features include shortening and bowing of the radius and ulna in the forearms,

How is Mesomelic dysplasia, Kantaputra type inherited?

Mesomelic dysplasia, Kantaputra type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mesomelic dysplasia, Kantaputra type typically begin?

Typical onset of Mesomelic dysplasia, Kantaputra type is neonatal. Age of onset can vary across affected individuals.